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Abstract
The primary function of the urothelium is to provide the tightest and most impermeable barrier in the body, i.e. the blood-
urine barrier. Urothelial plaques are formed and inserted into the apical plasma membrane during advanced stages of
urothelial cell differentiation. Currently, it is supposed that differentiation with the final formation of urothelial plaques is
hindered in cultured urothelial cells. With the aid of the high-resolution imaging technique of freeze-fracture replica
immunolabelling, we here provide evidence that urothelial cells in vitro form uroplakin-positive urothelial plaques, localized
in fusiform-shaped vesicles and apical plasma membranes. With the establishment of such an in vitro model of urothelial
cells with fully developed urothelial plaques and functional properties equivalent to normal bladder urothelium, new
perspectives have emerged which challenge prevailing concepts of apical plasma membrane biogenesis and blood-urine
barrier development. This may hopefully provide a timely impulse for many ongoing studies and open up new questions for
future research.
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Introduction
Urothelial plaques are ultrastructurally distinctive, highly
ordered structures made of crystalline arrays of 16-nm hexagon
shaped protein particles consisting of four integral membrane
proteins called uroplakins i.e. UPIa, UPIb, UPII and UPIIIa [1,2].
The latter are the most significant molecules in the apical plasma
membrane (PM) of the differentiated urothelial cells (UCs) that
line the urinary tract from the renal pelvis to the proximal urethra
[3,4]. Uroplakins contribute to the blood-urine barrier, the tightest
and most impermeable barrier in the body, by their structural
organization [5] and by hindering endocytosis from the apical PM
[6].
Although uroplakins were previously found in cultured UCs [7–
11], the prevailing view is that differentiation with the final
formation of urothelial plaques is hindered in cultured UCs.
Moreover, it is believed that cultured UCs revert to a more
undifferentiated ‘‘primitive’’ phenotype [7,12]. The widely held
assumption that uroplakins do not form urothelial plaques in
cultured UCs is based on immunofluorescence light microscopy
and standard thin section electron microscopy (EM).
In view of these conflicting data, we have now sought detailed
evidence for or against the presence of urothelial plaques positive
for uroplakins in cultured UCs by using the high-resolution
imaging technique of freeze-fracture EM combined with immu-
nogold labelling, i.e. freeze-fracture replica immunolabelling
(FRIL). Furthermore, the ultrastructural differentiation of cultured
UCs was determined by thin section and scanning EM and the
barrier function was assessed by measurement of transepithelial
electrical resistance (TER).
Using these different experimental approaches, we show that in
long-term cultures the UCs form an urothelium, in which the
superficial UCs express uroplakins and form uroplakin-positive
urothelial plaques indistinguishable from those of superficial UCs
in vivo. Our findings illustrate the recent impact of the FRIL
technique in demonstrating the localization of uroplakins and the
structure and formation of urothelial plaques in UCs both in vivo
and in vitro.
Materials and Methods
Specimens and Chemically Defined Medium for
Urothelial Cells
The experiments were approved by the Veterinary Adminis-
tration of the Slovenian Ministry of Agriculture and Forestry
(permit no. 34401-1/2010/6) in compliance with the Animal
Health Protection Act and the Instructions for Granting Permits
for Animal Experimentation for Scientific Purposes. Urinary
bladders were obtained from adult male mice; strain ICR CD1.
Bladders were handled aseptically and immediately immersed in
medium for urothelial cells, i.e. UroM consisting of equal parts of
MCDB 153 medium (Sigma, Taufkirchen, Germany) and
Advanced-DMEM medium (Invitrogen, Gibco, Paisley, UK) and
supplemented with adenine (15 mg/ml), insulin (5 mg/ml), hydro-
cortisone (0.5 mg/ml), phosphoetanolamine (0.1 M), glutamax
(4 mM), streptomycine (100 mg/ml) and penicillin (100 mg/ml).
The final Ca
2+ concentration was 2 mM. Normal UCs, gently
scraped with a scalpel blade from the bladder of an adult male
mouse, were used as a control, i.e. UCs in vivo.
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Primary mouse urothelial cultures were prepared as described
previously [10,13]. Briefly, the urothelium and underlying lamina
propria were separated from the submucosa and muscle layer
mechanically using sterile forceps. The isolated mucosa was cut
into explants (2–3 mm
2, 10–12 explants for each mouse bladder),
which were transferred onto 0.4 mm porous membranes (BD
Falcon, Bedford, USA). Each explant was orientated and spread
out, so that the urothelium was on the upper side. Culture medium
was introduced into the well containing the porous membrane, so
that the urothelium was positioned at the air-liquid interface.
Medium was changed daily with the exception of weekends. After
2 months, the molecular and ultrastructural status of UCs growing
onto the porous membrane was analyzed.
Transepithelial Resistance (TER)
TER across the urothelia grown on porous membranes (BD
Falcon) was measured for 4 months (from the 4
th week, when the
UCs reached confluence till the 17
th week). Cultured urothelia
were grown in medium UroM for 14 weeks. Then one-third of
cultured urothelia was propagated in a medium supplemented
with 2.5% fetal bovine serum (FBS, Gibco) and two-thirds were
propagated in the same medium for an additional 3 weeks. For
measuring TER an epithelial voltohmmeter (EVOM & EVOMX,
Sarasota) and STX2 electrodes were used. The measured TER
was corrected by subtracting the mean resistance of blank porous
membranes (150 Vcm
2) and the results were expressed as Vcm
2 6
SE. Urothelial TER values were averaged and compared by a two-
tailed Student’s t-test; p values less than 0.05 were considered
statistically significant.
Thin Section and Scanning Electron Microscopy
UCs were prepared for thin section and scanning EM as
described previously [9]. In brief, after 2 months of culturing the
UCs were fixed in 4% (w/v) paraformaldehyde and 2.5% (v/v)
glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4 for 2 h 45 min.
The fixation was followed by overnight rinsing in 0.1 M
cacodylate buffer. The samples were then postfixed in 1% (w/v)
osmium tetroxide for 1 h at 4uC, dehydrated in a graded series of
ethanol and embedded in Epon (Serva Electrophoresis, Heidel-
berg, Germany). Ultrathin sections were contrasted with uranyl
acetate and lead citrate and observed in a Philips CM100
transmission electron microscope. After dehydration through
a graded series of acetone, the samples for scanning EM were
dried at the critical point, spattered with gold and observed in
a Jeol 840A scanning electron microscope.
Freeze-fracture Replica Immunolabeling (FRIL)
This technique involves 1. splitting membranes at low
temperatures to give extensive planar views of the membrane
interior, 2. replicating the membrane’s structural detail by vacuum
deposition of platinum and carbon, 3. removing all but a molecular
layer of the cells by washing with sodium dodecyl sulphate, and 4.
applying antibody labelling techniques with electron-dense gold
particles to localize the uroplakin-positive urothelial plaques
(Fig. 1).
Full description of the methodology and nomenclature has been
reported previously [14,15]. In brief, UCs were cultured in
medium UroM at 37uC, 5% CO2 for 2 months. We performed
three independent FRIL experiments. Each experiment was
performed on the long-term primary urothelial cultures established
from the mouse urinary bladder explants. In sum, we analyzed 23
long-term primary urothelial cultures prepared from three urinary
bladders. After 2 months, the explants were removed and only the
UCs growing on the porous membranes were rapidly frozen,
freeze-fractured and platinum-carbon replicas were made follow-
ing the standard protocol used for freeze-fracture electron
microscopy. However, instead of removing the biological material
from the replica with bleach or acids, as in the conventional
technique, the replica was treated with Tris-bufferd 5 % sodium
dodecyl sulphate (SDS) with 30 mM sucrose, pH 8.3, overnight at
room temperature. The SDS removed the bulk of the biological
material from the replica so that structure was visible by EM,
leaving a single lipid monolayer and associated integral and
surface proteins adherent to the replica (Fig. 1). This remaining
layer was so thin that it did not obstruct the electron beam. After
SDS treatment the replicas were thoroughly washed in PBS and
incubated in blocking buffer (5% BSA, bovine serum albumin).
Uroplakins were then localized by immunogold labelling. Primary
rabbit polyclonal antibodies against all four uroplakins were
diluted 1:5000. The antibodies used were a rabbit polyclonal anti-
asymmetric unit membrane (AUM) antibody (a gift from Professor
Dr. T-T Sun), which is generated against total mature uroplakins
[16]. Secondary antibodies the goat anti-rabbit 18-nm gold
complexes were from Jackson Immunoresearch, West Grove,
NA, USA. Immunolabelled replicas were observed in a Philips 410
transmission electron microscope.
Results and Discussion
In order to determine whether the uroplakins particles are
formed in UCs in vitro and to examine the possibilities of their
Figure 1. Diagram illustrating the principle of FRIL to visualize
the location of uroplakins at high resolution in membranes.
The technique permits retention of a layer of molecules attached to the
platinum-carbon replica. The term ‘‘fracture-face’’ is reserved for the
interior views of membranes exposed by freeze fracturing. The term E
face is used for the half-membrane leaflet adjacent to the extracellular
space, while the term P face is used for that adjacent to the protoplasm
(i.e. cytoplasm). The integral membrane proteins uroplakins embedded
in the replica can be labelled using a primary antibody followed by
a secondary antibody coupled to colloidal gold. On examination in the
transmission electron microscope, the electron dense gold label is
clearly visible against the replica, marking the uroplakins in the plane of
the membrane.
doi:10.1371/journal.pone.0038509.g001
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primary mouse urothelial culture. Using different experimental
approaches, we determined the molecular and ultrastructural
differentiation and the functional property of in vitro developed
urothelium. We applied FRIL, which here provides unequivocal
evidence that UCs in vitro form uroplakin-positive urothelial
plaques.
Figure 2. Urothelial plaques are detected in the apical PM of UCs in vivo and in vitro. Immunogold labelling for uroplakins is seen on the E
faces of the apical PM of UCs in vivo (A) and in vitro (B). The maximum calliper diameters and the morphology of urothelial plaques are similar in UCs
in vivo and in vitro.
doi:10.1371/journal.pone.0038509.g002
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PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38509Figure 3. Urothelial plaque biogenesis in DFVs and apical PM of UCs in vitro. Images of urothelial plaques in the apical PM and membranes
of DFVs of UCs in vitro prepared by freeze-fracture electron microscopy with immunogold labelling for uroplakins. Abundant immunogold label is
seen in urothelial plaques on the E faces of the apical PM (A, B, short arrows), and also on E faces of DFV membranes (A, B, C, long arrows, and in B,
arrowheads). DFVs with uroplakin label could be seen near the Golgi apparatus (GA) (C, long arrows), from which probably the DFV membranes are
derived, and in close proximity to the apical PM (A, B). The number and ordering of uroplakin particles in urothelial plaques varies between DFVs. The
DFVs in B, marked with arrowheads, bear more uroplakin particles than those marked with long arrows. This could be interpreted as the sequential
assembly of uroplakin particles into DFV membranes. Variations in the number of uroplakin particles in the urothelial plaques are also seen in the
apical PM (A, B), suggesting that the gradual aggregation of small urothelial plaques into larger ones is not only limited to DFVs but still takes place in
the apical PM (D, long arrows). The edges of urothelial plaques appear rounded (A, thick arrows) or straight (B, thick arrows).
doi:10.1371/journal.pone.0038509.g003
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PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e38509Figure 4. Urothelium in vitro with the ultrastructural and functional properties of native urothelium. (A) FRIL, (B, C) thin section EM, (D)
TER measurements. (A) Image of urothelial plaques in the apical PM and membrane of DFV of UC in vitro prepared by freeze-fracture electron
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Figure 2 shows the localization of uroplakin-positive urothelial
plaques in normal mouse UCs in vivo (Fig. 2A) and in UCs
propagated in vitro for 2 months (Fig. 2B). The apical PM of UCs in
vitro exhibits plaques indistinguishable from those of UCs in vivo.
The plaques were found in all cultures analyzed. There was no
significant difference (P.0.05) between the maximum calliper
diameter of urothelial plaques in UCs in vivo (744643 nm, n=30)
and in vitro (710650 nm, n=30). Variations in the number of
uroplakin particles in the urothelial plaques were found in both
UCs in vivo and in vitro. The immunogold label was confined to the
E face of the apical PM (Fig. 2); no label was detected on the P face
in accordance with previous studies demonstrating the (uroplakin)
subunits to be located in the external half-membrane leaflet,
penetrating through to the exterior [17]. The terms E face and P
face are applied to the interior view of the half-membrane leaflets
of the PM that lie adjacent to the extracellular space and the
protoplasm, i.e. cytoplasm, respectively (Fig. 1).
Apart from positive labelling of uroplakins on the apical PM E
face, prominent labelling was apparent on the E faces of discoidal-
or fusiform-shaped vesicles (DFVs) in the cytoplasm (Fig. 3A, B).
DFVs are involved in the transport of uroplakins to the apical PM
[18–21]. Freeze-fracture images disclose that DFVs are often seen
in close association with the apical PM (Fig. 3A, B) and the Golgi
microscopy with immunogold labelling for uroplakins. The uroplakin-positive urothelial plaques in the apical PM (asterisk) and the cytoplasm (arrow)
correspond to (B) rigid-looking, concave shaped apical PM structures (asterisk in B) and membranes of the DFVs (arrow in B), respectively, that are
visible by thin section EM. Hinge regions are marked by arrowheads in A and B. Note close association of DFVs with the apical PM in A and B. (C) The
UCs in vitro, like UCs in vivo, are organized into the urothelium with the basal (b), intermediate (i) and superficial (s) cells. (D) The TER of urothelia
grown on porous membrane was measured for 4 months, from week 4 onwards. Each point represents the mean TER (6SE) of urothelia. Urothelia
were grown for 14 weeks in the medium UroM without fetal bovine serum (FBS, n=12), then the two-thirds of urothelia were propagated in the same
medium (n=8) and the other one-third in UroM with 2.5% FBS (n=4) for an additional 3 weeks. Note the significant increase in the TER of urothelia,
which were transferred from the medium UroM without FBS to UroM with FBS.
doi:10.1371/journal.pone.0038509.g004
Figure 5. Urothelium in vitro with the tight junctions and scalloped appearance of the apical PM. (A) Thin section EM and (B–D) Scanning
EM. (A) Superficial UCs are connected with well-developed cell junctions (noticeable in the direction of thick arrow). Note accumulation of FVs close
to the apical PM. The hinge region is marked with arrowhead. (B) Overview of the apical surface showing the superficially-positioned UCs and well
developed cell borders between them (thick arrows). (C) The surface topography of superficial UCs in vitro reveals the scalloped appearance of the
apical PM. Arrows denote the regions, which in the FRIL and thin section EM micrographs correspond to the urothelial plaques. Tight junction is seen
between two superficial UCs (thick arrows). (D) At higher magnification the scanning EM shows the urothelial plaques as darker areas of hexagonal
morphology (arrow) and hinge regions as brighter ridges (arrowhead). In inset, at the same magnification the apical PM with urothelial plaques and
the hinge regions in superficial UC in vivo.
doi:10.1371/journal.pone.0038509.g005
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observations [19] and earlier studies on intact tissue [20]. The
Golgi apparatus did not contain uroplakin-positive urothelial
plaques, which is in agreement with the study of Hudoklin et al
[21], which show no uroplakin labelling of the Golgi apparatus on
cryo-ultrathin sections. The size of urothelial plaques on the
membrane of DFVs resemble those found in close proximity to
larger ones in the apical PM (Fig. 3D). The obvious associations of
DFVs containing urothelial plaques in the cytoplasm and the
apical PM revealed in this study indicate that these features play
important roles in urothelial plaque biogenesis and growth. These
associations are ideally configured to function in the intracellular
synthesis and transport as well as the cytoplasmic-plasmalemmal
transfer and the progressive incorporation of uroplakins into
urothelial plaques in the apical PM.
In long-term Cultures the UCs Develop Ultrastructural
and Functional Characteristics of Highly Differentiated
Superficial UCs in vivo
Urothelial plaques are unique and specific assemblies of highly
differentiated superficial UCs composed of uroplakins [3]. In this
study, we demonstrated that by using FRIL we can unequivocally
show that rigid-looking, concave shaped membrane structures that
are visible by thin section EM (asterisk in Fig. 4B) and the darker
areas of hexagonal morphology that are visible by scanning EM
(arrows in Fig. 5C, D) correspond to uroplakin-positive urothelial
plaques (asterisk in Fig. 4A). Additionally, we proved that the
cytoplasmic DFVs containing uroplakin-positive urothelial plaques
(arrow in Fig. 4A) and narrow rims of membranes without
particles – termed hinges (arrowhead in Fig. 4A) correspond to
DFVs that are visible by thin section EM (arrow and arrowhead in
Fig. 4B). These results further support the idea that UCs in vitro
retain the capability for synthesis of the uroplakin particles and
their arrangement into urothelial plaques.
In order to examine whether our in vitro established urothelia
(Fig. 4C) are ‘‘tight’’ epithelia with a TER .500 Vcm
2, according
to the definition of Fromter and Diamond [22], we measured the
TER of cultured UCs growing on a porous membrane for 4
months (Fig. 4D). We started to measure TER in the 4
th week,
when the confluence was reached in each of the UC cultures
(n=12). TER measurements over the course of the 4 months
revealed that urothelia grown in such culture conditions form
‘‘tight’’ epithelia. Urothelia grown in a medium UroM without
FBS had a mean TER from 534 6 20 Vcm
2 to 1165 6 85 Vcm
2.
Thin section and scanning EM of the long-term urothelial
cultures clearly demonstrated well-developed tight junctions
between superficial UCs (Fig. 5A–C). Our previous immunocyto-
chemical studies on primary urothelial cultures have already
revealed occludin-, ZO-1-, claudin-4- and claudin-8-containing
tight junctions between the new superficial UCs in 7-day primary
urothelial cultures [13]. We therefore suggest that in our in vitro
established long-term normoplastic urothelial cultures, the high
TER is maintained by the well-developed cell junctions, and not
with the uroplakin-positive urothelial plaques. This interpretation
is consistent with the findings of Hu and co-workers [5], which
demonstrated that UPIII-deficient urothelium exhibits a normal
TER but has significantly elevated water permeability and to
a lesser extent also increased urea permeability. Additional studies
are underway to better define the permeability parameters of the
long-term urothelial cultures.
To evaluate the viability and functional responsiveness of the
long-term urothelial culture, one-third of cultured urothelia was
transferred into a medium supplemented with 2.5% FBS in the
14
th week. TER measurements revealed that addition of 2.5 %
FBS induces the significant increase in TER (Fig. 4D). From the
14
th to 17
th week the urothelia grown with FBS had enhanced the
barrier function. TER measurements over the course of the 3
weeks revealed a mean TER from 816 6 22 Vcm
2 to 1721 6 45
Vcm
2.
These findings show the significant effect of serum on urothelial
TER, which is in agreement with our recent study on the
hyperplastic urothelial models [23]. They further confirmed the
functional capacity of the urothelial in vitro model. Moreover, the
findings support the idea that UCs in long-term urothelial culture
retain their viability and still respond to extracellular signals, e.g.
the added serum.
Conclusions
Our results have a number of applications. The established
urothelial culture model can be used as a research tool for
investigating the cellular-molecular mechanisms of apical PM
biogenesis, which are crucial for development of the blood-urine
barrier. The prevailing hypothesis proposes that differentiation
with the final formation of urothelial plaques is hindered in
cultured UCs. By revisiting the localization of uroplakins in
cultured UCs with the FRIL technique, the first unequivocal
evidence for uroplakin-positive urothelial plaques in UCs in vitro
has been achieved. Apart from positive labelling of uroplakins in
cytoplasmic DFVs and apical PM, FRIL has also provided new
insights into the dynamics of urothelial plaque formation. Among
the key questions to be addressed in future studies are whether
additional types of protein other than uroplakins are involved in
urothelial plaque formation and how the final size of an urothelial
plaque is determined and regulated.
To sum up, the findings discussed illustrate the recent impact of
the FRIL technique in demonstrating the localization of
uroplakins and the structure and formation of urothelial plaques
in UCs both in vivo and in vitro. The information this approach
provides is unique and we expect that further exploitation of the
FRIL technique in future studies may advance our understanding
of the biology of the blood-urine barrier.
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